搜尋結果
Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
CNBC· 2 小時前Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a ...
CNBC Daily Open: Le Pen's 28-year old protégé
CNBC· 10 小時前This report is from today's CNBC Daily Open, our international markets newsletter. Markets ...
Forbes Daily: Nvidia Continues To Prove It’s An AI Juggernaut
Forbes· 12 小時前A critical new industry is emerging in the fight against climate change—one focused on removing ...
HSBC Research: MO Avg. Daily GGR Falls 18% WoW Last Wk; MGM CHINA, SANDS CHINA LTD, WYNN MACAU ...
AASTOCKS.com· 3 小時前AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services ...
CNBC Daily Open: Nvidia unseats Microsoft as world's most valuable company
CNBC· 1 日前This report is from today's CNBC Daily Open, our international markets newsletter. CNBC Dai ...
Gilead's long-acting HIV drug superior to daily pill Truvada in study
Reuters· 4 小時前, opens new tab said on Thursday a late-stage study showed its injectable drug, lenacapavir, ...
... tariffs will sabotage its ambition to be the leader of the green transition: China Daily e ...
China Daily· 50 分鐘前Following an investigation that concluded the Chinese electric vehicle industry "benefits from unfair subsidization", the ...
MUNDIAL and Daily Paper join forces for UNITE collaboration featuring two unique shirts ...
Goal.com· 7 日前The wing-back is coming off the back of one of the most successful seasons in German football ...
5 Examples Of How Brands Are Replacing Their Employees With AI
Forbes· 12 小時前Whenever you read about a large company deploying AI they will never say the obvious: this ...
98 Degrees In Boston: Heat Wave Shatters Temperature Records Throughout Northeast
Forbes· 12 小時前A heat dome brought dangerously high temperatures and the first heat wave of the season to ...